Development and Implementation of an AI-Driven Early Detection System for Non-Communicable Diseases

Non-Communicable Diseases (NCDs), including cardiovascular diseases, diabetes, cancer, and chronic respiratory conditions, pose a significant global health burden, accounting for over 70% of deaths worldwide. Early detection is crucial for effective intervention, reducing morbidity, and improving patient outcomes. The integration of Artificial Intelligence (AI) in healthcare has demonstrated substantial potential in revolutionizing early detection systems through predictive analytics, machine learning, and big data processing. This explores the development and implementation of an AI-driven early detection system for NCDs, focusing on leveraging diverse data sources such as electronic health records (EHRs), wearable health devices, and genetic information. The proposed system utilizes machine learning models to identify patterns, assess risk factors, and provide early warnings, enabling timely medical intervention. Key components of the system include data acquisition and preprocessing, model selection and training, integration with healthcare infrastructure, and deployment strategies ensuring reliability and scalability. The implementation phase involves collaboration with healthcare providers to validate AI models, ensuring accuracy, fairness, and compliance with healthcare regulations such as HIPAA and GDPR. Ethical considerations, including data privacy, algorithmic bias, and patient trust, are critical in system adoption. Case studies of AI-based early detection programs highlight successes, challenges, and lessons for future advancements. This also discusses future directions in AI-driven preventive healthcare, emphasizing the role of personalized medicine and real-time monitoring. With continuous advancements in AI and big data analytics, AI-powered early detection systems offer transformative potential in reducing the NCD burden, ultimately improving public health and healthcare efficiency. However, challenges in model interpretability, regulatory compliance, and system integration must be addressed for widespread adoption. This review underscores AI's potential to enhance early detection, optimize healthcare delivery, and shape the future of proactive disease management.